Editas Medicine, Inc. Common Stock EDIT

$2.84 +0.71% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-08-07 View →
4 FORM 4 2026-08-05 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
4 FORM 4 2026-07-29 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
8-K 8-K 2026-06-18 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
424B5 424B5 2026-05-26 View →
8-K FORM 8-K 2026-05-26 View →
8-K FORM 8-K 2026-05-26 View →
424B5 424B5 2026-05-26 View →
8-K FORM 8-K 2026-05-26 View →
8-K 8-K 2026-05-14 View →
10-Q 10-Q 2026-05-05 View →
8-K 8-K 2026-05-05 View →
DEF 14A DEF 14A 2026-04-28 View →
8-K 8-K 2026-04-07 View →
8-K 8-K 2026-03-27 View →
4 FORM 4 2026-03-16 View →
4 FORM 4 2026-03-16 View →
4 FORM 4 2026-03-16 View →
10-K 10-K 2026-03-09 View →
8-K 8-K 2026-03-09 View →
4 FORM 4 2026-03-04 View →
4 FORM 4 2026-03-04 View →
4 FORM 4 2026-03-04 View →
4 FORM 4 2025-12-04 View →
4 FORM 4 2025-12-04 View →
4 FORM 4 2025-12-04 View →
10-Q 10-Q 2025-11-10 View →
8-K 8-K 2025-11-10 View →
8-K 8-K 2025-10-09 View →
4 FORM 4 2025-09-04 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.84
Market Cap
$433.10 million
52-Week Range
$1.66 – $4.54
Average Volume
1.76 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.